Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Aflibercept on the PBS

Drugline Volume 405

The Pharmaceutical Benefits Scheme (PBS) listing for aflibercept was expanded on 1 October 2020. Aflibercept is now subsidised for the treatment of subfoveal choroidal neovascularisation, in addition to macular oedema secondary to diabetes or…

Read more

Lorlatinib on the PBS

Drugline Volume 404

Lorlatinib was recently added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of metastatic non-small cell lung cancer (NSCLC). To be eligible for subsidised therapy, patients must have evidence of an anaplastic lymphoma…

Read more

Removal of Bufexamac Products

Drugline Volume 403

From 18th September 2020, all products containing bufexamac will be removed from the Australian Register of Therapeutic Goods (ARTG). This action follows an investigation by the Therapeutic Goods Administration (TGA), which concluded that the…

Read more

Acalabrutinib on the PBS

Drugline Volume 402

On September 1, acalabrutinib was listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of relapsed or refractory chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). Acalabrutinib is an inhibitor of Bruton’s…

Read more

Hydrochlorothiazide and Skin Cancer

Clinical Article

Evidence suggests that hydrochlorothiazide is associated with an increased risk of carcinoma in sun-exposed tissues. It is theorised that this may be due to the photosensitising properties of hydrochlorothiazide. A recent Australian study demonstrated…

Read more

Zoster vaccine and immunosuppression

Drugline Volume 400

The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding the use of Zostavax® in people with compromised immune function. Zostavax® is a live, attenuated varicella-zoster vaccine indicated for the prevention of herpes…

Read more
Load More

October 2020

Aflibercept on the PBS (Oct. 16 2020)

Lorlatinib on the PBS (Oct. 02 2020)

September 2020

July 2020

May 2020

March 2020

December 2019

November 2019

October 2019

New Warning for Febuxostat (Oct. 18 2019)

Naloxone Nasal Spray (Oct. 04 2019)

April 2019

New High-Strength Insulin (Apr. 18 2019)

Tofacitinib Safety Issue (Apr. 05 2019)

March 2019

February 2019

January 2019

December 2018

October 2018

September 2018

August 2018

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012